Search Result "Gliflozin"
Risks Associated with SGLT2 Inhibitors: An Overview
Journal: Current Drug Safety
Volume: 13 Issue: 2 Year: 2018 Page: 84-91
Author(s): Mahakpreet Singh,Anoop Kumar
When Serum C-Peptide Measurement Drives Adequate Diabetes MellitusDiagnosis and Therapy: A Case Report
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 23 Issue: 7 Year: 2023 Page: 1005-1009
Author(s):
Review on Characteristics and Analytical Methods of RemogliflozinEtabonate: An Update
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 9 Year: 2022 Page: 1341-1350
Author(s): Jagdish K. Sahu,Sanjay Sharma,Vallabh D. Suryavanshi
Sodium-glucose Cotransporter 2 Inhibitors: The Pleiotropic Mechanisms of Actions
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 18 Issue: 2 Year: 2018 Page: 86-93
Author(s): Panteleimon Pantelidis,Andreas Kalliakmanis,Christos Mitas,Michail Sideris,Charalampos Grassos,Andreas Pittaras,Athanasios Manolis
Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Journal: Current Diabetes Reviews
Volume: 13 Issue: 4 Year: 2017 Page: 405-423
Author(s): Matthew J. Levine
The Beneficial Hemodynamic Actions of SGLT-2 Inhibitors beyond the Management of Hyperglycemia
Journal: Current Medicinal Chemistry
Volume: 27 Issue: 39 Year: 2020 Page: 6682-6702
Author(s): Charalampos Loutradis,Eirini Papadopoulou,Elena Angeloudi,Asterios Karagiannis,Pantelis Sarafidis
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition
Journal: Current Vascular Pharmacology
Volume: 15 Issue: 2 Year: 2017 Page: 96-102
Author(s): V. Tsimihodimos, T.D. Filippatos, S. Filippas-Ntekouan, M. Elisaf
Cardiovascular Benefit of SGLT2 Inhibitors in the Therapeutics of Diabetes Mellitus: A Close Look beyond the Horizon
Journal: Current Drug Targets
Volume: 19 Issue: 9 Year: 2018 Page: 1051-1057
Author(s): Dylan Y. Ren,Yingmei Zhang
Management of Type 2 Diabetes in Acute Coronary Syndromes: Current State andFuture Perspectives
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 5 Year: 2023 Page: 365-367
Author(s):
Canagliflozin : A New Hope in the Antidiabetic Armamentarium
Journal: Recent Patents on Cardiovascular Drug Discovery
Volume: 8 Issue: 3 Year: 2013 Page: 216-220
Author(s): Vasiliki K. Katsi,Christos A. Michalakeas,Charalambos E. Grassos,Georgia D. Vamvakou,John P. Lekakis,Dimitris Tousoulis,Christodoulos I. Stefanadis,Thomas K. Makris,Ioannis E. Kallikazaros